glp-1 drink powder Supergut GLP1 Daily Support - Raspberry Lemon - High Fiber Supplement for Women & Men Metavo Electrolytes + Collagen Zesty

Contact your Optum Rx representative or complete our online form

Take advantage of our full weight loss services for continued support and nutritional education

Tirzepatide is a GLP-1 and GIP receptor agonist licensed in the UK for type 2 diabetes mellitus treatment Lightheadedness occurs through reduced fluid intake from gastrointestinal effects, blood pressure lowering from weight loss, or hypoglycaemia when combined with insulin or sulfonylureas Seek immediate medical attention for loss of consciousness, chest pain, severe confusion, or persistent vomiting preventing fluid intake Management includes maintaining adequate hydration (6-8 glasses daily), eating regular small meals, rising gradually from sitting or lying positions, and medication review with your GP Report frequent or concerning lightheadedness to your healthcare team within 24 hours for dose adjustment or investigation of alternative causes Table of Contents Why Mounjaro Can Cause Lightheadedness Mounjaro (tirzepatide) is a glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus

Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g

Patients who have had gallbladder removal may notice temporary digestive adjustments, particularly after fatty meals

Provided a robust manufacturing protocol for scale-up